Less Alzheimer's pathology with angiotensin receptor blocker use
(HealthDay)—In autopsy findings, patients treated with angiotensin receptor blockers (ARBs) show less Alzheimer's disease (AD)-related pathology, according to a study published online Sept. 10 in the Archives of Neurology.
Sep 12, 2012
0
0